切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2023, Vol. 17 ›› Issue (01) : 31 -36. doi: 10.11817/j.issn.1673-9248.2023.01.006

临床研究

血流导向装置治疗颅内未破裂动脉瘤的疗效与影响因素分析
连万成1, 姚京2, 吴泽涛2, 何毅2, 伍健明2,(), 张猛2,()   
  1. 1. 230032 合肥,安徽医科大学深圳二院临床学院;518116 深圳大学附属华南医院神经外科
    2. 518035 深圳大学第一附属医院神经外科
  • 收稿日期:2022-07-26 出版日期:2023-02-01
  • 通信作者: 伍健明, 张猛
  • 基金资助:
    深圳市2020年基础研究重点项目(基2020N325)

Flow-diverters in treating unruptured intracranial aneurysms: a study of efficacy and influencing factors

Wancheng Lian1, Jing Yao2, Zetao Wu2, Yi He2, Jianming Wu2,(), Meng Zhang2,()   

  1. 1. Shenzhen Second People's Hospital Clinical College, Anhui Medical University, Hefei 230032, China; Department of Neurosurgery, South China Hospital of Shenzhen University, Shenzhen 518116, China
    2. Department of Neurosurgery, the First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China
  • Received:2022-07-26 Published:2023-02-01
  • Corresponding author: Jianming Wu, Meng Zhang
引用本文:

连万成, 姚京, 吴泽涛, 何毅, 伍健明, 张猛. 血流导向装置治疗颅内未破裂动脉瘤的疗效与影响因素分析[J/OL]. 中华脑血管病杂志(电子版), 2023, 17(01): 31-36.

Wancheng Lian, Jing Yao, Zetao Wu, Yi He, Jianming Wu, Meng Zhang. Flow-diverters in treating unruptured intracranial aneurysms: a study of efficacy and influencing factors[J/OL]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(01): 31-36.

目的

探讨单纯血流导向装置或联合弹簧圈治疗颅内未破裂动脉瘤的短中期疗效以及影响因素。

方法

回顾性连续纳入深圳大学第一附属医院血管神经外科2019年1月至2020年12月采用Tubridge血流导向装置治疗的未破裂颅内动脉瘤患者手术数据及3~18个月随访数据。有完整随访资料者共46例(均以最后1次随访数据为准),分析病例的临床资料、手术结果(闭塞率)、动脉瘤形态学特征情况。采用单因素结合多因素非条件Logistic回归分析方法,分析动脉瘤闭塞率的影响因素。

结果

46例患者根据随访结果分为完全闭塞组(28例)与不完全闭塞组(18例)。2组患者年龄、动脉瘤类型、有无侧支方面比较差异均无统计学意义(P均>0.05)。单纯使用Tubridge血流导向装置(密网支架)栓塞治疗者32例,辅助弹簧圈治疗者14例,手术成功率100%。在3~18个月术后影像学随访过程中,在完全闭塞组密网支架联合弹簧圈治疗者占12/28,而未完全闭塞组密网支架联合弹簧圈治疗者仅占2/18,2组比较差异具有统计学意义(χ2=4.792,P=0.029)。进一步对照分析发现动脉瘤有无侧支发出、是否联合弹簧圈治疗、随访时间>6个月是影响动脉瘤闭塞的主要因素(OR=0.101、9.832、9.266,P=0.003、0.009、0.021)。

结论

血流导向装置治疗颅内未破裂动脉瘤在>6个月的时间随访时有着良好的闭塞率,且联合弹簧圈辅助治疗时闭塞率更高,但动脉瘤存在侧支血管会影响其闭塞率。

Objective

To explore the short and medium-term efficacy and influencing factors of simple flow diverter stents (FD) or combined with coil embolization in treating unruptured intracranial aneurysms.

Methods

The clinical data and 3-18 months of follow-up data of patients were collected and analyzed, who were treated with Tubridge (TB, Microport, Shanghai, CN) for intracranial aneurysm at the First Affiliated Hospital of Shenzhen University from January 2019 to December 2020. The clinical data, surgical outcomes (occlusion rate), and morphological characteristics of aneurysms were analyzed. For the above data, the influencing factors of occlusion rate were analyzed by univariate combined with multivariate unconditional logistic regression analysis.

Results

A total of 46 cases with complete data were included in the study. According to the follow-up results, they were divided into the completed occlusion group (n=28) and the incomplete occlusion group (n=18). There were no statistically significant differences in ages of onset, aneurysm types, with or without collateral vessels (all P>0.05). Among all patients, 32 patients were embolized with blood flow guidance device alone and the other 14 patients were assisted with coil embolization. The success rate of the operation was 100%. During postoperative imaging follow-up for 3-18 months, treatment with FD combined with coil embolization accounted for 12/28 in the completed occlusion group, and accounted for 2/18 in the incomplete occlusion group, showing a significantly statistical difference (χ2=4.792, P=0.029). Further comparative analysis showed that the presence or absence of collateral branches, with or without coil embolization, and follow-up time >6 months were the major factors affecting the primary closure of aneurysms (OR=0.101, 9.832, 9.266; P=0.003, 0.009, 0.021).

Conclusion

The occlusion rate of unruptured intracranial aneurysms treated with FDs was reasonable during the follow-up of more than 6 months, and the occlusion rate is higher when combined with coil embolization; however, the occlusion rate of aneurysms will be affected when there are collateral vessels.

图1 未破裂颅内动脉瘤患者单纯支架治疗造影图像。图a术前正位示右侧颈内C4段动脉瘤,大小约4 mm×3 mm,宽基底;图b为术后即刻复查,置入4.5 mm×30 mm Tubridge血流支架后见动脉瘤内造影剂滞留;图c术后8个月复查,见动脉瘤基本不显影;图d为术中置入动脉瘤支架后三维重建图
图2 未破裂颅内动脉瘤患者支架联合弹簧圈治疗图像。图a术前正位示左侧颈内动脉眼段动脉瘤约6 mm×6 mm,宽基底;图b为术后即刻复查,完全释放支架后颈内动脉通畅,动脉瘤不显影;图c为8个月后复查,见颈内动脉分支通畅,动脉瘤未显影;图d为血流导向装置1枚+弹簧圈3枚术后三维重建图
表1 未破裂的颅内动脉瘤患者不同治疗方式组间基线临床资料比较
表2 颅内动脉瘤闭塞率的单因素非条件Logistic回归分析
表3 颅内动脉瘤闭塞率的多因素Logistic回归分析
19
Etminan N, Rinkel GJ. Unruptured intracranial aneurysms: development, rupture and preventive management [J]. Nat Rev Neurol, 2016, 12(12): 699-713.
20
Jia L, Wang J, Zhang L, et al. Evaluating the Tubridge™ flow diverter for large cavernous carotid artery aneurysms [J]. Chin Neurosurg J, 2020, 6(1): 36.
1
卢旺盛, 吕明. 从过去走向未来, 颅内动脉瘤的诊治历程 [J]. 中国卒中杂志, 2018, 13(10): 1009-1011.
2
Brisman JL, Song JK, Newell DW. Cerebral aneurysms [J]. N Engl J Med, 2006, 355(9): 928-939.
3
Frösen J, Tulamo R, Paetau A, et al. Saccular intracranial aneurysm: pathology and mechanisms [J]. Acta Neuropathol, 2012, 123(6): 773-786.
4
van Gijn J, Kerr RS, Rinkel GJE. Subarachnoid haemorrhage [J]. Lancet, 2007, 369(9558): 306-318.
5
Wiebers DO, Whisnant JP, Huston J, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment [J]. Lancet, 2003, 362(9378): 103-110.
6
郑超波, 陈林辉, 吴炯, 等. 血流导向装置治疗颅内未破裂复杂动脉瘤单中心短中期疗效分析 [J]. 浙江医学, 2021, 43(2): 205-208.
7
Chancellor B, Raz E, Shapiro M, et al. Flow diversion for intracranial aneurysm treatment: trials involving flow diverters and long-term outcomes [J] Neurosurgery, 2020, 86(Suppl 1): S36-S45.
8
王驰, 刘长江, 杨鹏飞, 等. 神经外科医师对颅内动脉瘤血管内栓塞术后DSA即刻结果判读的影响 [J]. 中国脑血管病杂志, 2016, 13(1): 3-7.
9
Foutrakis GN, Yonas H, Sclabassi RJ. Saccular aneurysm formation in curved and bifurcating arteries [J]. AJNR Am J Neuroradiol, 1999, 20(7): 1309-1317.
10
Siddiqui AH, Kan P, Abla AA, et al. Complications after treatment with pipeline embolization for giant distal intracranial aneurysms with or without coil embolization [J]. Neurosurgery, 2012, 71(2): E509-E513, discussion E513.
11
Sprengers ME, Schaafsma J, van Rooij WJ, et al. Stability of intracranial aneurysms adequately occluded 6 months after coiling: a 3T MR angiography multicenter long-term follow-up study [J]. AJNR Am J Neuroradiol, 2008, 29(9): 1768-1774.
12
Narata AP, Obradó L, Moyano RK, et al. Cerebral aneurysm occlusion at 12-month follow-up after flow-diverter treatment: statistical modeling for V&V with real-world data [J]. Front Med Technol, 2021, 3: 705003.
13
Schaafsma JD, Sprengers ME, van Rooij WJ, et al. Long-term recurrent subarachnoid hemorrhage after adequate coiling versus clipping of ruptured intracranial aneurysms [J]. Stroke, 2009, 40(5): 1758-1763.
14
Sluzewski M, Menovsky T, van Rooij WJ, et al. Coiling of very large or giant cerebral aneurysms: long-term clinical and serial angiographic results [J]. AJNR Am J Neuroradiol, 2003, 24(2): 257-262.
15
van Rooij WJ, Sprengers ME, Sluzewski M, et al. Intracranial aneurysms that repeatedly reopen over time after coiling: imaging characteristics and treatment outcome [J]. Neuroradiology, 2007, 49(4): 343-349.
16
Wermer MJ, Greebe P, Algra A, et al. Incidence of recurrent subarachnoid hemorrhage after clipping for ruptured intracranial aneurysms [J]. Stroke, 2005, 36(11): 2394-2399.
17
耿介文, 翟晓东, 吉喆, 等. 中国颅内未破裂动脉瘤诊疗指南2021 [J].中国脑血管病杂志, 2021, 18(9): 634-664.
18
Yang H, Jiang H, Ni W, et al. Treatment strategy for unruptured intracranial aneurysm in elderly patients: coiling, clipping, or conservative? [J]. Cell Transplant, 2019, 28(6): 767-774.
[1] 陆婷, 范晴敏, 王洁, 万晓静, 许春芳, 董凤林. 超声引导下经皮穿刺置管引流对重症急性胰腺炎的疗效及应用时机的选择[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 511-516.
[2] 邢颖, 程石. 巨脾外科治疗现状与介入治疗序贯手术策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 253-258.
[3] 冯铭, 孙洪涛. 动脉瘤性蛛网膜下腔出血的颅内压监测与管理[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 248-253.
[4] 唐必英, 李钢. 治疗时机对动脉瘤性蛛网膜下腔出血患者预后的影响[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 213-219.
[5] 杨金朔, 吴桥伟, 王春雷, 史怀璋. 脑血管内支架成形术后再狭窄的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(03): 174-179.
[6] 赖凌峰, 黄小飞, 丁聪, 周小兵. 血流导向装置治疗血泡样动脉瘤的临床效果分析[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(03): 166-170.
[7] 周章明, 余水, 梁张. 老年破裂前循环动脉瘤患者的急诊显微手术治疗研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(02): 106-111.
[8] 高振轩, 谢晨, 曹绍东, 甘中伟, 周倍, 罗朝川, 王子齐, 葛煜彤, 张伟光. 高分辨率核磁共振在颅颈大动脉狭窄介入治疗中的临床应用进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(02): 112-119.
[9] 牟超鹏, 宗斌, 刘奕, 史美英, 徐杜娟, 冯春光. 经远端桡动脉与经常规桡动脉行急诊冠脉介入诊疗后穿刺部位血肿的对比[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 275-282.
[10] 陈芳, 王建英, 曹建用, 刘丽, 罗晓琴. 基于分析-设计-开发-实施-评价模式的叙事护理培训在产科预防性介入治疗中的应用[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 392-396.
[11] 李超迪, 刘娟芳, 闫肃, 秦胜东, 张镐哲, 常琼方, 韩新巍, 张建好. 血管性介入治疗在宫颈癌大出血患者中的临床疗效[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 217-220.
[12] 周宝林, 刘曦, 谌浩, 王金, 马雪琴. 温敏水凝胶在血管内栓塞治疗中的研究进展[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 244-249.
[13] 张长东, 李庚, 钟禹成, 田军, 尚小珂, 董念国. 2023年先天性心脏病介入治疗年度报告[J/OL]. 中华心脏与心律电子杂志, 2024, 12(02): 72-78.
[14] 周洪千, 张煜坤, 顾天舒, 胡苏涛, 姜超, 张雪, 张昊, 陶华岳, 刘行, 刘彤, 陈康寅. 既往出血性脑卒中患者行经皮冠脉介入治疗后不良事件的危险因素分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 323-329.
[15] 段丽娟, 蒋艳, 樊朝凤, 曹华. 颅内动脉瘤介入治疗术后不留置导尿管的效果及安全性[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(02): 104-109.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?